Seeking AlphaWed, 13 May 2026 20:40:51 GMTAlnylam Pharmaceuticals, Inc. (ALNY) Presents at Bank of America Global Healthcare Conference 2026 TranscriptALNY+2.81%
MarketBeatWed, 13 May 2026 20:15:15 GMTAlnylam Pharmaceuticals Backs TTR Outlook as AMVUTTRA Access, Prescriber Growth BuildALNY+2.81%
Zacks Investment ResearchFri, 01 May 2026 17:10:26 GMTAlnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y GrowthALNY+2.81%
Seeking AlphaFri, 01 May 2026 16:25:55 GMTAlnylam Pharmaceuticals: The RNAi Leader Continues To Grind Through A Quieter YearALNY+2.81%
Seeking AlphaThu, 30 Apr 2026 16:51:44 GMTAlnylam Pharmaceuticals, Inc. (ALNY) Q1 2026 Earnings Call TranscriptALNY+2.81%
Zacks Investment ResearchThu, 30 Apr 2026 15:01:48 GMTAlnylam (ALNY) Reports Q1 Earnings: What Key Metrics Have to SayALNY+2.81%
Zacks Investment ResearchThu, 30 Apr 2026 14:26:19 GMTAlnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue EstimatesALNY+2.81%
Investors Business DailyThu, 30 Apr 2026 13:15:11 GMTAlnylam Pharma Surges After Sales Of Its Biggest Moneymaker CatapultALNY+2.81%
Zacks Investment ResearchWed, 29 Apr 2026 14:15:37 GMTAlnylam (ALNY) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesALNY+2.81%
Zacks Investment ResearchMon, 27 Apr 2026 15:01:41 GMTVertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseALNY+2.81%
Zacks Investment ResearchThu, 23 Apr 2026 17:11:31 GMTWhy Alnylam (ALNY) is Poised to Beat Earnings Estimates AgainALNY+2.81%
Zacks Investment ResearchThu, 23 Apr 2026 15:03:07 GMTAlnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseALNY+2.81%
Zacks Investment ResearchTue, 07 Apr 2026 14:11:11 GMTIs the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?ALNY+2.81%
24/7 Wall StreetWed, 01 Apr 2026 11:05:46 GMT5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats UpALNY+2.81%
Seeking AlphaTue, 24 Mar 2026 20:24:51 GMTAlnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise TranscriptALNY+2.81%
Zacks Investment ResearchThu, 19 Mar 2026 15:36:04 GMTCan Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?ALNY+2.81%
BenzingaThu, 05 Mar 2026 18:35:56 GMTTenaya Therapeutics Stock Jumps After New Alnylam DealALNY+2.81%
Seeking AlphaMon, 02 Mar 2026 21:07:57 GMTAlnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference TranscriptALNY+2.81%
